Insider Trading History of Mathews Charles

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Mathews Charles since 2012. The trader's CIK number is 1190315. At the time of the last reporting, Mathews Charles was the Director of Apollo Endosurgery, Inc.. (stock ticker symbol APEN). Also see all insider trading activities at Apollo Endosurgery, Inc..

Note that in the past MATHEWS CHARLES also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Avanir Pharmaceuticals (AVNR) by Mathews Charles

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 AVNR 5,000 $13,475 0 $0 0 $0

Yearly summary of insider trading at Apollo Endosurgery, Inc. (LPTN) by Mathews Charles

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 LPTN 0 $0 0 $0 3,485 $0
2015 LPTN 0 $0 0 $0 5,715 $0
2014 LPTN 0 $0 0 $0 2,858 $0
2012 LPTN 5,000 $24,900 0 $0 2,858 $0


Insider trading activities at 2 companies by Mathews Charles:

1. Avanir Pharmaceuticals (AVNR)

2. Apollo Endosurgery, Inc. (LPTN)

Table 1. Insider trading of Avanir Pharmaceuticals (AVNR) by Mathews Charles

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-03-06 AVNR Buy 5,000 2.69 13,475

Table 2. Insider trading of Apollo Endosurgery, Inc. (LPTN) by Mathews Charles

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-09 LPTN Option Ex 3,485 .00 0
2015-04-22 LPTN Option Ex 5,715 .00 0
2014-02-10 LPTN Option Ex 2,858 .00 0
2012-12-19 LPTN Buy 5,000 4.98 24,900
2012-11-20 LPTN Option Ex 2,858 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mathews Charles (Director of Apollo Endosurgery, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.